Status:
RECRUITING
Etomidate Versus Propofol in CABG Surgery
Lead Sponsor:
Hartford Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The objective of this single-blinded randomized controlled interventional clinical trial is to learn about the efficacy and long-term safety of etomidate compared to propofol as an anesthesia inductio...
Eligibility Criteria
Inclusion
- Patients scheduled for elective open coronary arteries bypass graft CABG surgery
- Patients with American Society of Anesthesiology (ASA) physical status score I- IV
- Patients with the ability to speak and read both English and Spanish
Exclusion
- Emergency CABG surgery, STAT cases, and add-on cases.
- Refusal or lack of providing the study consent
- Patients with a known current adrenocortical insufficiency
- A patient who is presenting with any kind of shock, (e.g. septic, hypovolemic, cardiogenic, etc.)
- Patients with chronic steroid use (defined as the use of glucocorticoids within 6 months preoperatively)
- Patients with a known allergy to etomidate or propofol.
- Patients with a known seizure disorder.
- Patients who are enrolled in other clinical research studies that can compete with this study.
Key Trial Info
Start Date :
December 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06068764
Start Date
December 5 2023
End Date
August 1 2026
Last Update
December 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06106